Finance

Lists
Why is SGRY up 2,24%?
Dive Deeper
SGRY:NASDAQ
Surgery Partners Inc
13,71 US$
+2,24%
(+0,30) 1D
13,71 US$
0,00% (0,00)
After hours
Closed: 7 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGRY...
Open
13,36 US$
High
13,96 US$
Low
13,34 US$
Mkt. cap
1,79 მლრდ.
Avg. vol.
2,34 მლნ.
Volume
9,00
52-wk high
23,44 US$
52-wk low
11,41 US$
EPS
-0,69 US$
Beta
1,91
Shares outstanding
130,92 მლნ.
No. of employees
16 ათ.
Open
13,36 US$
High
13,96 US$
Low
13,34 US$
Mkt. cap
1,79 მლრდ.
Avg. vol.
2,34 მლნ.
Volume
9,00
52-wk high
23,44 US$
52-wk low
11,41 US$
EPS
-0,69 US$
Beta
1,91
Shares outstanding
130,92 მლნ.
No. of employees
16 ათ.
News stories
From web sources and news partners
About Surgery Partners Inc
CEO-
Employees16 ათ.
Founded2004
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 9 analysts giving stock ratings to SGRY in the past 3 months
Buy
Buy
6
Hold
3
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SGRY in the last 3 months.
Highest
Current 13,71 US$
24,00 US$ (+75,05%)
Average
18,50 US$ (+34,94%)
Lowest
14,00 US$ (+2,12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Hold
Maintained
14,00 US$
+2,1%
10/07/2026
Ben Hendrix
RBC Capital
Buy
Maintained
19,00 US$
+38,6%
09/29/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
20,00 US$
+45,9%
09/18/2026
Ryan Langston
TD Cowen
Buy
Reiterated
19,00 US$
+38,6%
09/18/2026
Benjamin Rossi
J.P. Morgan
Hold
Reiterated
15,00 US$
+9,4%
09/14/2026
Bill Sutherland
StoneX
Buy
Reiterated
24,00 US$
+75,1%
08/11/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
18,00 US$
+31,3%
08/10/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
08/11/2026
Gary Taylor
TD Cowen
Buy
Reiterated
19,00 US$
+38,6%
08/11/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
19,00 US$
+38,6%
07/13/2026
Brian Tanquilut
Jefferies
Buy
Maintained
17,00 US$
+24%
05/06/2026
A.J. Rice
UBS
Buy
Maintained
21,00 US$
+53,2%
03/10/2026
Last report
10 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
0,10 US$ / 0,06 US$
+59,57%beat
Revenue / Est. (USD)
848,90 მლნ. / 830,32 მლნ.
+2,24%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
821,50 მლნ.
885,00 მლნ.
810,90 მლნ.
848,90 მლნ.
Cost of goods sold
626,20 მლნ.
672,80 მლნ.
650,70 მლნ.
658,70 მლნ.
Cost of revenue
626,20 მლნ.
672,80 მლნ.
650,70 მლნ.
658,70 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,40 მლნ.
23,70 მლნ.
39,30 მლნ.
36,30 მლნ.
Operating expense
60,20 მლნ.
78,70 მლნ.
76,10 მლნ.
73,70 მლნ.
Total operating expenses
686,40 მლნ.
751,50 მლნ.
726,80 მლნ.
732,40 მლნ.
Operating income
135,10 მლნ.
133,50 მლნ.
84,10 მლნ.
116,50 მლნ.
Other non operating income
1,60 მლნ.
8,10 მლნ.
-
1,40 მლნ.
EBT including unusual items
30,80 მლნ.
42,60 მლნ.
-3,30 მლნ.
32,30 მლნ.
EBT excluding unusual items
65,40 მლნ.
72,50 მლნ.
19,10 მლნ.
53,10 მლნ.
Income tax expense
5,50 მლნ.
13,60 მლნ.
-1,20 მლნ.
2,60 მლნ.
Effective tax rate
17,86%
31,92%
36,36%
8,05%
Other operating expenses
-1,70 მლნ.
-4,90 მლნ.
-1,70 მლნ.
-1,90 მლნ.
Net income
-22,70 მლნ.
-15,00 მლნ.
-35,90 მლნ.
-15,00 მლნ.
Net profit margin
-2,76%
-1,69%
-4,43%
-1,77%
Earnings per share
0,13
0,12
-0,03
0,10
Interest and investment income
-
-
-
-
Interest expense
-76,50 მლნ.
-75,70 მლნ.
-69,10 მლნ.
-71,20 მლნ.
Net interest expenses
-76,50 მლნ.
-75,70 მლნ.
-69,10 მლნ.
-71,20 მლნ.
Depreciation and amortization charges
39,50 მლნ.
59,90 მლნ.
38,50 მლნ.
39,30 მლნ.
EBITDA
174,60 მლნ.
193,40 მლნ.
122,60 მლნ.
155,80 მლნ.
Gain or loss from assets sale
15,60 მლნ.
11,40 მლნ.
4,30 მლნ.
2,40 მლნ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები